Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Clinical research trials and Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis. Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis clinical trial. Participants frequently obtain the most expert healthcare available for their Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis



Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

For Condition: Ulcerative Colitis
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , University of Vermont
Synopsis: OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.
Details: PROTOCOL OUTLINE: This is a randomized study. Patients are stratified by extent of disease. Patients are randomly assigned to oral 4-aminosalicylic acid (4-ASA) or placebo administered daily for 6 weeks. Optional 4-ASA is available to all patients for up to 1 year. Concurrent therapy with low-dose sulfasalazine, prednisone, or equivalent is allowed.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/80 Years
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: - Mildly to moderately severe ulcerative colitis - Patient age: 18 to 80
Total Enrollment: 30

Location and Contact Information:

Overall Study Official:
WarrenBeeken,  Study Chair,  University of Vermont


Additional Information:
Study ID Numbers:
  199/12012;  UVT-12012
Study Start Date: June 1996
Record last reviewed: December 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004810

Other Ulcerative Colitis Studies:
1. Research Study in Patients With Severe Ulcerative Colitis

2. Immune Regulation in Ulcerative Colitis or Crohn's Disease

3. Quality of Life in Pediatric Inflammatory Bowel Disease

4. Study of Infliximab for the treatment of patients with active Ulcerative Colitis.

5. FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Related Studies:

Other Ulcerative Colitis Clinical Trials
Other Clinical Trials
Other Clinical Trials

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

Modify your Search

  Other Ulcerative Colitis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103